Diagenic Exercises 10-for-1 Reverse Stock Split | GenomeWeb
Home » Diagenic Exercises 10-for-1 Reverse Stock Split

Diagenic Exercises 10-for-1 Reverse Stock Split

Jun 03, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagenic recently announced a 10-for-1 reverse stock split, which took effect on May 30.

As a result of the split, each share of the company's stock was bumped up to NOK.50 ($.09) from NOK.05. After the split, the Norwegian firm had about 27 million shares of common stock outstanding.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jan 27, 2016

CombiMatrix Initiates 1-for-15 Reverse Stock Split

Sep 15, 2016

Great Basin Scientific Plans Reverse Stock Split

Dec 09, 2015

Great Basin Shareholders Approve Reverse Stock Split

Oct 08, 2015

MetaStat Effects One-for-15 Reverse Stock Split

Dec 11, 2015

In Brief This Week: Roche; Danaher; Transgenomic; and More

Aug 15, 2016

Qiagen Announces $250M Synthetic Share Repurchase Program

The Scan

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Even More Data to Mine

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

New Spaces in Connecticut

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Healthier, If Not Longer, Life

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

What's Popular?

In Microarrays & Multiplexing

  1. New Blood Pressure, Hypertension Loci Identified Through Large Analyses

  2. Team Pins Origins of Dog Domestication in Central Asia

  3. Genetic Makeup of African-American Populations Influenced by Ancestry-Biased Migrations

  4. TB Biosciences Raises $1.5M in Series A Financing

  5. Post-IPO, Biocartis Looks to Build out MDx Platform, Develop New Technologies

    Premium

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.